"The times they are a-changin'." In reply to El-Zaidy et al.: AVXS-101 (Onasemnogene Abeparvovec) for SMA1: comparative study with a prospective natural history cohort

相似书籍

• Onasemnogene‐abeparvovec administration to premature infants with spinal muscular atrophy
  由: Stephen M. Brown, et al.
  出版: (2024-11-01)
• Cost-effectiveness analysis of using onasemnogene abeparvocec (AVXS-101) in spinal muscular atrophy type 1 patients
  由: Daniel C. Malone, et al.
  出版: (2019-01-01)
• Short-Term Safety and Efficacy of Onasemnogene Abeparvovec in 10 Patients with Spinal Muscular Atrophy: Cohort Study
  由: Kristina S. Nevmerzhitskaya, et al.
  出版: (2021-12-01)
• Onasemnogene Abeparvovec Administration via Peripherally Inserted Central Catheter: A Case Report
  由: Inmaculada Pitarch Castellano, et al.
  出版: (2024-05-01)
• Experience of using gene replacement therapy with Zolgensma® (onasemnogene abeparvovec) in real clinical practice in Russia
  由: S. B. Artemyeva, et al.
  出版: (2022-02-01)